Pro Share Advisors LLC Arvinas, Inc. Transaction History

Pro Share Advisors LLC

$36.7 Billion
Q1 2024

A detailed history of Pro Share Advisors LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 13,832 shares of ARVN stock, worth $414,960. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,832

Previous 11,644 18.79%

Holding current value

$414,960

Previous $479,000 19.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$36.38 - $52.31 $79,599 - $114,454	2,188 Added 18.79%	13,832 $570,000
Q4 2023 Feb 14, 2024	BUY	$14.19 - $42.33 $165,228 - $492,890	11,644 New	11,644 $479,000
Q2 2023 Aug 10, 2023	BUY	$21.73 - $31.43 $9,213 - $13,326	424 Added 4.5%	9,842 $244,000
Q1 2023 May 11, 2023	SELL	$26.15 - $37.26 $32,504 - $46,314	-1,243 Reduced 11.66%	9,418 $257,000
Q4 2022 Feb 02, 2023	BUY	$32.47 - $57.24 $26,722 - $47,108	823 Added 8.37%	10,661 $364,000

Q3 2022 Nov 04, 2022	BUY	$41.87 - $57.99 $9,755 - $13,511	233 Added 2.43%	9,838 $437,000
Q2 2022 Aug 01, 2022	SELL	$36.01 - $74.24 $169,967 - $350,412	-4,720 Reduced 32.95%	9,605 $404,000
Q1 2022 May 10, 2022	SELL	$60.27 - $81.57 $205,882 - $278,643	-3,416 Reduced 19.25%	14,325 $964,000
Q4 2021 Feb 08, 2022	BUY	$65.85 - $96.21 $107,993 - $157,784	1,640 Added 10.19%	17,741 $1.46 Million
Q3 2021 Nov 12, 2021	SELL	$73.2 - $107.87 $294,556 - $434,068	-4,024 Reduced 20.0%	16,101 $1.32 Million
Q2 2021 Aug 13, 2021	BUY	$60.45 - $84.26 $234,546 - $326,928	3,880 Added 23.88%	20,125 $1.55 Million
Q1 2021 May 14, 2021	BUY	$58.19 - $91.37 $135,931 - $213,440	2,336 Added 16.79%	16,245 $1.07 Million
Q4 2020 Feb 09, 2021	BUY	$20.19 - $84.93 $80,961 - $340,569	4,010 Added 40.51%	13,909 $1.18 Million
Q3 2020 Nov 13, 2020	SELL	$22.99 - $36.34 $7,609 - $12,028	-331 Reduced 3.24%	9,899 $234,000
Q2 2020 Aug 03, 2020	BUY	$29.88 - $56.74 $108,105 - $205,285	3,618 Added 54.72%	10,230 $343,000
Q1 2020 May 15, 2020	SELL	$33.0 - $54.5 $154,803 - $255,659	-4,691 Reduced 41.5%	6,612 $266,000
Q4 2019 Feb 12, 2020	BUY	$15.39 - $44.38 $173,953 - $501,627	11,303 New	11,303 $464,000

Others Institutions Holding ARVN

# of Institutions

236

Shares Held

64.9M

Call Options Held

119K

Put Options Held

94.2K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.6B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Arvinas, Inc. Transaction History